TrialJournal of translational medicine2011

Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.

Akio Ido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.